AdAlta (ASX:1AD) Share Price and News

Market Cap (19-Sep) $7,649,007 (1,598th)	Close (30-Jun) $0.024 0 (0%)	Volume (30-Jun) 2,170,184	Shortsold (2-Feb) 3,141 (0.00%) (662nd)
52w High $0.008	52w Low $0.002	P/E -	EPS 0

	Subject
	1AD 1AD Ann: AD-214 clinical trial approval
	1 (current) 2 3
	1AD 1AD Ann: Change in substantial holding
	1AD 1AD Ann: Change in substantial holding
	1AD 1AD Ann: Change of Director's Interest Notice x 2 (TO & DF)
	1AD 1AD Ann: Top 20 Option Holders & Distribution Schedule
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Investor Summit live and recorded presentation
	1AD 1AD Ann: Investor presentation
	1AD 1AD Ann: Rights Offer results
	1AD 1AD Ann: Notice of change of exercise price of options
	1AD 1AD Ann: Despatch of Rights Offer documentation
	1AD 1AD Ann: Investor Presentation - Rights Offer Webinar
	1AD 1AD Ann: Letter to Ineligible Foreign Shareholders
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Letter to Eligible Shareholders
	1AD 1AD Ann: Letter to Optionholders
	1AD 1AD Ann: Target Market Determination
	1AD 1AD Ann: Prospectus
	1AD 1AD Ann: Proposed issue of securities - 1AD
	1AD 1AD Ann: Rights Offer to fund early return to clinic and growth
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Notification of cessation of securities - 1AD
	1AD 1AD Ann: Notification regarding unquoted securities - 1AD
	1AD 1AD Ann: Final Director's Interest Notice
	1AD 1AD Ann: Retirement of Non-Executive Director
	1AD 1AD Ann: ShareCafe webinar presentation 3 Mar 2023
	1AD 1AD Ann: Half Yearly Report and Accounts
	1AD 1AD Ann: Spark Plus Singapore Investor Presentation
	1AD 1AD Ann: Becoming a substantial holder
	1AD 1AD Ann: Cleansing Notice under Section 708A
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Application for quotation of securities - 1AD
	1AD 1AD Ann: Proposed issue of securities - 1AD
	1AD 1AD Ann: Proposed issue of securities - 1AD
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Change in substantial holding
	1AD 1AD Ann: Publication highlights I-body potential in osteoporosis
	1AD 1AD Ann: Change of Director's Interest Notice x 2
	1AD 1AD Ann: AdAlta welcomes new substantial shareholders
	1AD 1AD Ann: Ceasing to be a substantial holder
	1AD 1AD Ann: Second Japan patent for AD-214
	1AD 1AD Ann: Results of Meeting
	1AD 1AD Ann: Chair address and CEO presentation to AGM
	1AD 1AD Ann: AD-214 progress and priorities webinar presentation
	1AD 1AD Ann: AD-214 progress and priorities
	1AD 1AD Ann: Balance of R&D Tax Incentive Refund received
	1AD 1AD Ann: Quarterly Appendix 4C and Activities Report
	1AD 1AD Ann: Letter to Shareholders, Notice of AGM & Proxy Form
	1AD 1AD Ann: 1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer
	1AD 1AD Ann: Notification of cessation of securities - 1AD

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	11,589,500	0.00 (0.00%)
12-Sep	$0.00	477,000	0.00 (0.00%)
11-Sep	$0.00	4,503,439	0.00 (0.00%)
05-Sep	$0.00	0	0.00 (0.00%)
04-Sep	$0.00	397,500	0.00 (0.00%)
03-Sep	$0.00	8,553,500	0.00 (25.00%)
29-Aug	$0.00	496,263	0.00 (0.00%)
28-Aug	$0.00	799,825	0.00 (20.00%)
22-Aug	$0.01	6,410,928	+0.00 (25.00%)
21-Aug	$0.00	2,372,593	+0.00 (60.00%)
15-Aug	$0.00	4,667,230	0.00 (0.00%)
14-Aug	$0.00	2,990,568	0.00 (16.67%)
07-Aug	$0.00	118	+0.00 (20.00%)
31-Jul	$0.00	75,962	+0.00 (25.00%)
30-Jul	$0.00	1,666,667	0.00 (0.00%)
4 up, 3 down, and 8 flat days

High $0.03	Low $0.02	Trades 24	Turnover $54,432	Volume 2,170,184
30 June 2023 at 3:59pm

High $0.03	Low $0.02	Trades 24	Turnover $54,432	Volume 2,170,184
30 June 2023 at 3:59pm

AdAlta Health Care

$0.024 (0%)

$0.024 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices